2nd COVID-19 vaccine gets public review ahead of US decision
WASHINGTON (AP) — A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday as government advisers convened for a public review of its safety and effectiveness.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
